logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal

Guardant Health Shares Soar 28% on Blowout Quarterly Results, Surging Test Volumes

Oct 30, 2025

Life Science

Hedge Fund BVF Makes Massive Bet on Structure Therapeutics as Stock Skyrockets 214%

Trump’s Price-Cutting Vow Rattles Novo Nordisk, But Valuation and Pipeline Offer Compelling Case

Oct 29, 2025

Life Science

BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain

BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain

Oct 26, 2025

Life Science

"Great Warfighting Capabilities": Trump's Palantir Endorsement Clashes with Burry's Bearish Bets

Nvidia-Backed AI Biotech Recursion Soars 25% in a Month: Time to Buy or Beware?

Oct 21, 2025

Life Science

Who Will Lead in 2026? Analysts Identify the Next Cohort of U.S. Growth Stocks

Goldman’s 2026 Playbook: Ride Dividend Growth in Healthcare, Utilities, Industrials

Oct 21, 2025

Energy, Life Science

Forced Selling, Not Defaults, Breaks Credit Markets

Oct 20, 2025

Energy, Life Science

The everything bubble fear hides a deeper weakness

Oct 20, 2025

Energy, Life Science

Seeking Reliable Income? Top Picks in High-Yield Healthcare Stocks

Seeking Reliable Income? Top Picks in High-Yield Healthcare Stocks

Oct 19, 2025

Life Science

Grail Soars on $110 Million Samsung Investment to Commercialize Cancer Test in Asia

Grail Soars on $110 Million Samsung Investment to Commercialize Cancer Test in Asia

Oct 16, 2025

Life Science

Looking for a Cheap Biotech Stock? Exelixis Fits the Bill

Looking for a Cheap Biotech Stock? Exelixis Fits the Bill

Oct 14, 2025

Life Science

Friday’s Crack Exposed Hidden Systemic Leverage

Oct 14, 2025

Life Science

Melt-Up Myths and the Fragility of Late-Stage Rallies

Oct 10, 2025

Life Science

2x Valuation Gap: BIO vs. CRL — Who’s Wrong?

Beyond the Pfizer Rally: Here Are 2 Biotech Stocks With Deeper Potential

Oct 8, 2025

Life Science

Supercharged Gene-Editing: Intellia's 63% Rally Just The Start, Say Analysts

Supercharged Gene-Editing: Intellia’s 63% Rally Just The Start, Say Analysts

Oct 7, 2025

Life Science

S&P 500 Futures Drift; Gold Near 4,000 as DXY Firms

Oct 7, 2025

Life Science

LG Electronics’ $1.3 Billion India IPO Sold on First Day

Oct 7, 2025

Life Science

Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most?

Investing in Psychedelic Stocks: A New Frontier in Mental Health Treatment

Oct 6, 2025

Life Science

AstraZeneca AZN Hits Record as Trump Delays Drug Tariffs

Oct 2, 2025

Life Science

  • ‹‹ Previous
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada